Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome ; volume:22 ; number:1 ; day:31 ; month:10 ; year:2021 ; pages:1-9 ; date:12.2021
Respiratory research ; 22, Heft 1 (31.10.2021), 1-9, 12.2021
- Urheber
-
Kwon, Byoung Soo
Choe, Jooae
Chae, Eun Jin
Hwang, Hee Sang
Kim, Yong-Gil
Song, Jin Woo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-021-01879-6
- URN
-
urn:nbn:de:101:1-2022010918423296650490
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kwon, Byoung Soo
- Choe, Jooae
- Chae, Eun Jin
- Hwang, Hee Sang
- Kim, Yong-Gil
- Song, Jin Woo
- SpringerLink (Online service)
Ähnliche Objekte (12)
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Prevalence and clinical features of interstitial lung disease in patients with psoriasis
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Prevalence and clinical features of interstitial lung disease in patients with psoriasis
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
The natural history of progressive fibrosing interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Prevalence and clinical features of interstitial lung disease in patients with psoriasis
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)